Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Texcell Unveils State-of-the-Art Viral Clearance Testing Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

Texcell Unveils State-of-the-Art Viral Clearance Testing Facility

Will support biosafety studies for monoclonal antibodies, gene therapies, and medical devices coming to the market.

By: Anthony Vecchione

Texcell, a contract research organization (CRO) that specializes in viral testing, viral clearance, bioassays, in vivo testing, and GMP cell banking, has opened its newest testing facility in Frederick, MD. 

In a statement, the company said that the new building represents a significant milestone in Texcell’s commitment to advancing the viral safety of biotherapeutics and medical devices.

Designed to support simultaneous viral clearance and biosafety studies, this 27,000 square-foot facility is built with a modular design that enhances the flexibility required in today’s contract testing environment.

The new facility will support biosafety studies for monoclonal antibodies, gene therapies, and medical devices coming to the market.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics